subscribeSubscribe
GoodRx and Biogen Collaborate to Enhance Enrollment Experience for Providers

GoodRx and Biogen Collaborate to Enhance Enrollment Experience for Providers
BUSINESSWIRE
13 Oct 2022
Share Share
SMC approves diroximel fumarate as multiple sclerosis treatment

SMC approves diroximel fumarate as multiple sclerosis treatment
PHARMAFILE
08 Feb 2022
Share Share
MHRA authorises Vumerity for multiple sclerosis patients

MHRA authorises Vumerity for multiple sclerosis patients
Lucy Parsons PHARMATIMES
19 Nov 2021
Share Share
European Commission grants marketing authorisation for Vumerity

European Commission grants marketing authorisation for Vumerity
Anna Begley EUROPEANPHARMACEUTICALREVIEW
17 Nov 2021
Share Share
The European Commission Grants Marketing Authorization for VUMERITY®

The European Commission Grants Marketing Authorization for VUMERITY®
GLOBENEWSWIRE
16 Nov 2021
Share Share
New Data at ECTRIMS 2021 Highlight Biogen’s Focus on Patient-Centered Outcomes

New Data at ECTRIMS 2021 Highlight Biogen’s Focus on Patient-Centered Outcomes
GLOBENEWSWIRE
13 Oct 2021
Share Share
Euro Roundup: CHMP recommends drugs from Biogen & Roche, knocks back Pfizer

Euro Roundup: CHMP recommends drugs from Biogen & Roche, knocks back Pfizer
Nick Paul Taylor RAPS
23 Sep 2021
Share Share
CHMP Recommends VUMERITY for Approval in European Union for Multiple Sclerosis

CHMP Recommends VUMERITY for Approval in European Union for Multiple Sclerosis
GLOBENEWSWIRE
17 Sep 2021
Share Share
Biogen`s lagging Vumerity faces `critical` stretch ahead: CEO

Biogen`s lagging Vumerity faces `critical` stretch ahead: CEO
E.Sagonowsky FIERCE PHARMA
23 Jul 2020
Share Share
Alkermes Receives $150M Biogen Milestone

Alkermes Receives $150M Biogen Milestone
CONTRACT PHARMA
12 Nov 2019
Share Share